Login / Signup

Late relapses in Hodgkin lymphoma - should we search for the needle in the haystack?

Tarec Christoffer El-GalalyIngrid Glimelius
Published in: British journal of haematology (2022)
Hodgkin lymphoma is among the most curable cancers. For patients in remission for 24 months, residual lifetime becomes close to that of the background population. However, late relapses can occur after several years and, as shown by Andersen et al., the outcomes are not always good. Commentary on: Andersen MD, Hamilton-Dutoit S, Modvig L, Vase M, Christiansen I, Christensen JH, et al. Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma - A study from the Danish Lymphoma Registry. Br J Haematol 2022;198:50-61.
Keyphrases
  • hodgkin lymphoma
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • type diabetes
  • metabolic syndrome
  • adipose tissue
  • patient reported outcomes
  • patient reported